Flow Neuroscience
Develops a medically approved brain stimulation headset and therapy app for treating depression at home.
About
Flow Neuroscience offers the Flow FL-100, the first and only FDA-approved at-home transcranial direct current stimulation (tDCS) treatment for adults aged 18 and older with moderate to severe Major Depressive Disorder. This neuromodulation treatment can be used as a standalone therapy or as an adjunct to antidepressant medication, with US availability expected in summer 2026. The company highlights its product's favorable safety profile and potential to reduce suicidal ideation and avoid psychiatric hospital admissions. Teams look it up for HealthTech, MedTech, Digital Therapeutics.
Frequently asked
What does Flow Neuroscience do?
Flow Neuroscience is a HealthTech company that offers Hardware. Teams look it up for MedTech, Digital Therapeutics. It is based in Malmö, Sweden and was founded in 2016. Public records show $22M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Flow Neuroscience raised?
Flow Neuroscience has raised a total of $22M in funding. The most recent round on record is Series A.
Where is Flow Neuroscience headquartered?
Flow Neuroscience is headquartered in Malmö, Sweden.
When was Flow Neuroscience founded?
Flow Neuroscience was founded in 2016.
What industry does Flow Neuroscience operate in?
Flow Neuroscience operates in HealthTech, MedTech, Digital Therapeutics.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.